טוען...
GlycA is not a useful biomarker of inflammation in sickle cell disease
INTRODUCTION: Sickle cell disease (SCD) is a multisystemic disorder, the pathology being driven by recurrent inflammation particularly during a vaso-occlusive crisis. GlycA, a composite measure of protein glycation, is a sensitive biomarker for disorders associated with vascular inflammation. We det...
שמור ב:
| הוצא לאור ב: | Int J Lab Hematol |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6419740/ https://ncbi.nlm.nih.gov/pubmed/30152174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijlh.12907 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|